InnoCare Pharma Limited (SHA:688428)
China
· Delayed Price · Currency is CNY 20.35
+0.36 (1.80%)
At close: May 13, 2025, 2:57 PM CST
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 18.47 billion as of May 13, 2025. Its market cap has increased by 113.50% in one year.
Market Cap
18.47B
Enterprise Value
13.16B
Revenue
1.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
20.35
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 11.23B to 18.47B, an increase of 64.56%. That is a compound annual growth rate of 10.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 18.47B | 55.60% |
| Dec 31, 2024 | 11.87B | -4.38% |
| Dec 29, 2023 | 12.42B | -43.12% |
| Dec 30, 2022 | 21.83B | 16.78% |
| Dec 31, 2021 | 18.69B | 27.74% |
| Dec 31, 2020 | 14.63B | 30.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 322.32B |
| Shenzhen Mindray Bio-Medical Electronics | 277.13B |
| WuXi AppTec | 169.69B |
| Zhangzhou Pientzehuang Pharmaceutical., | 124.60B |
| Aier Eye Hospital Group | 120.58B |
| Shanghai United Imaging Healthcare | 114.72B |
| Sichuan Biokin Pharmaceutical | 105.46B |
| Yunnan Baiyao Group Co.,Ltd | 101.83B |